Another meta-analysis of four randomized, placebo-controlled trials found evidence of a reduction in fasting plasma glucose concentration and no improvement of glycated hemoglobin concentration in subjects with type 2 diabetes mellitus supplemented with acetyl-L-carnitine (ALCAR) (44)
Photo by Freepik Written by Navneet Kaur, M.Sc
These treatments are offered in a supportive, medically supervised environment to ensure both safety and results
General subcutaneous guidance: Clean vial stopper and skin with alcohol
High blood sugar levels can damage blood vessels and neurons, too, contributing to dementia. He also points out that chronic inflammation is linked to neurodegenerative diseases
Here is what went into this page specifically: I pulled the full text of the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine on May 11, 2025 (DOI: 10.1056/NEJMoa2416394) and cross-referenced it with the Phase 3 TRIUMPH-4 topline readout from Eli Lilly on December 11, 2025